Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2026-01-01 @ 11:25 AM
Study NCT ID:
NCT00451035
Status:
TERMINATED
Last Update Posted:
2021-07-15
First Post:
2007-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2008-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-20
First Submit QC Date:
None
Study First Post Date:
2007-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-05-13
Results First Submit QC Date:
None
Results First Post Date:
2021-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-14
Last Update Post Date:
2021-07-15
Last Update Post Date Type:
ACTUAL